Page last updated: 2024-10-31

methylphenidate and Cancer Pain

methylphenidate has been researched along with Cancer Pain in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.

Research Excerpts

ExcerptRelevanceReference
"This review potentially supports the use of methylphenidate for opioid-induced sedation, cognitive decline and fatigue in cancer patients."4.98The Use of Methylphenidate for Physical and Psychological Symptoms in Cancer Patients: A Review. ( Andrew, BN; Guan, NC; Jaafar, NRN, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrew, BN1
Guan, NC1
Jaafar, NRN1

Reviews

1 review available for methylphenidate and Cancer Pain

ArticleYear
The Use of Methylphenidate for Physical and Psychological Symptoms in Cancer Patients: A Review.
    Current drug targets, 2018, Volume: 19, Issue:8

    Topics: Analgesics, Opioid; Animals; Cancer Pain; Central Nervous System Stimulants; Cognitive Dysfunction;

2018